Forecast

There is no analyst data available for this company.

News Go to news feed

Comvita returns to profit in FY 2026 — revenue rises to 213m NZD

Comvita reported a net profit after tax of 7.7m NZD for the financial year 2026 on revenue of 213m NZD. Revenues in North America more than doubled to 58.7m NZD, gross margin rose to 53.9%, and operating cash flow improved to 40.3m NZD. After a balance sheet restructuring, net debt of 62.4m NZD turned into a net cash position of 0.5m NZD; management did not provide a formal forecast for FY 2027 and does not expect to pay a dividend. The company will focus going forward on disciplined growth, product innovation and expansion into strategic markets such as the US and Southeast Asia. » More on de.investing.com
Comvita reports operational turnaround in H1 FY26 — shares rise 17%

Comvita returned to profit in the first half of FY26 and delivered a significant operational turnaround, sending the shares up 17.2%. Revenue rose 18.3% to NZ$118.0 million, normalized EBIT reached NZ$10.0 million and net profit after tax was NZ$4.6 million. Operating cash flow and free cash flow improved markedly, net debt fell 40.4% to NZ$48.7 million and inventory was cut by 53.1%. Drivers were cost discipline, strong growth in North America and product innovation; management maintains full-year normalized EBIT guidance of NZ$14.3 million and is pursuing a recapitalization planned by April 2026. » More on de.investing.com

Historical dividends Dividends

All dividend metrics All metrics

In 2024, COMVITA LTD has already paid €0.00653 in dividends. The last payout was in April 2024.

Financials

In the last quarter, COMVITA LTD had revenue of €57.82M and net profit of €2.25M

(EUR)	Dec 2025	YoY
Revenue	57.82M	-
Gross profit	27.91M	-
Net profit	2.25M	-
EBITDA	5.58M	-

Fundamentals

Metric	Value
Market capitalization	€25.8M
Number of shares	72.22M
52-week high/low	€1.34 - €0.27
Dividends	No
Beta	0.27
P/E ratio	-0.60
PEG ratio	0.03
P/B ratio	0.96
P/S ratio	0.27

Company profile

Comvita Limited und seine Tochtergesellschaften produzieren und vermarkten natürliche Gesundheitsprodukte in Australien, Neuseeland, China, dem übrigen Asien, Nordamerika, Europa, dem Nahen Osten, Afrika und international. Das Unternehmen bietet Manuka-Honig, Propolis, Olivenblattextrakt, Medihonig und Hautpflegeprodukte, Gourmet-Honig, Elixiere und Lutschtabletten, Apfelessigprodukte sowie Produkte für die Mund- und Kindergesundheit an. Das Unternehmen bietet auch Lösungen für die Verdauungsgesundheit, für zu Ekzemen neigende Haut, für Energie, Herzgesundheit und zur Unterstützung des Immunsystems sowie für Sommer- und Reisebedarf. Darüber hinaus ist das Unternehmen in den Bereichen Imkereibesitz und -verwaltung, Immobilienbesitz und IP-Eigentum tätig. Comvita Limited wurde 1974 gegründet und hat seinen Sitz in Te Puke, Neuseeland.